STOCK TITAN

Cyabra agrees to $15.6M private placement

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(High)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

Cyabra, Inc. agreed to a private placement with an initial aggregate subscription amount of $15,610,120: $10,000,000 of new investment and $5,610,120 in subscription consideration to be satisfied through cancellation of $2,805,060 of outstanding debt. As of November 16, 2026, the initial closing had not occurred and Cyabra had received no proceeds; it was expected on or about December 2026, subject to conditions including stockholder approval and Cyabra satisfying its continued-listing deficiencies on Nasdaq. The securities include Series D preferred stock initially convertible at $0.15 per share and warrants initially exercisable at $0.15 per share after stockholder approval, with a five-year term.

The agreement also contemplates up to $30,000,000 in further investments over three years in $500,000 tranches, subject to conditions. Separately, Series A and B warrants, each for up to 8,045,980 common shares, were amended to reduce exercise prices from $0.50 and $0.45, respectively, to $0.15, with anti-dilution protection permitting a one-time exercise-price reduction following the Company's reverse stock split. The purchase agreement also contemplates a $50,000,000 equity line of credit whose final terms were being negotiated.

Filing Explained

The staged ten million dollars is conditional follow-on funding, not cash available to Cyabra now.

The report adds two follow-on funding commitments: Cyabra has not closed the initial financing or received proceeds, and the investor’s commitments of $5 million within 12 months and another $5 million within 18 months are conditional on the agreement’s terms and follow the initial closing.

Separately, Cyabra agreed to file a resale registration statement within two days after the initial closing for common shares issuable upon conversion of the preferred stock or exercise of the warrants; that filing is a future obligation, not a registration or share issuance already completed.

At June 30, 2026, reported cash was $794,000 and second-quarter operating cash outflow was $2,397,000, equal to 30.1 days of cash at that quarter’s outflow rate.

Sources and calculations
  • Available liquidity against the last reported quarterly operating outflow, in days at that rate $794,000 / ($2,397,000 / 91) = 30.1 days
Item 1.01 Entry into a Material Definitive Agreement Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Item 3.02 Unregistered Sales of Equity Securities Securities
The company sold equity securities in a private placement or other unregistered transaction.
Item 8.01 Other Events Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Initial aggregate subscription amount $15,610,120 Contemplated for the initial closing.
New investment $10,000,000 New investment component of the initial subscription amount; the press release describes it as cash.
Debt cancellation $2,805,060 Outstanding company indebtedness to be canceled as part of the initial closing consideration.
Additional investments Up to $30,000,000 Contemplated over three years in $500,000 tranches, subject to conditions.
Preferred stock conversion price $0.15 per share Initial conversion price for Series D preferred stock, subject to adjustment.
Amended warrant exercise price $0.15 per share Reduced from $0.50 for Series A warrants and $0.45 for Series B warrants, subject to the amendment terms.
Existing warrant shares Up to 8,045,980 shares each The Series A and Series B warrants each cover up to this number of common shares.
Equity line of credit $50,000,000 Contemplated by the purchase agreement; final terms were being negotiated.
anti-dilution protection mechanism technical
"anti-dilution protection mechanism permitting a one-time reduction"
pari passu financial
"paid, on a pari passu basis"
An instruction that different claims, securities, or creditors are treated equally and share rights or payments on the same priority level. For investors, it means their position will be paid or have voting power alongside others in the same class rather than being favored or subordinated—think of several people standing in one bus line who all get on together rather than some cutting ahead. That parity affects expected recovery in reorganizations, dividend order, and relative risk.
equity line of credit financial
"entering into a $50 million equity line of credit"
An equity line of credit is a loan that allows homeowners to borrow money against the value of their property, similar to having a flexible credit card secured by their home. It matters to investors because it provides a way for property owners to access cash for various needs, which can influence real estate markets and overall economic activity. This type of credit offers ongoing borrowing capacity, making it a valuable financial tool for those with significant property equity.
equity conditions financial
"including applicable equity conditions"
continued listing deficiencies regulatory
"satisfying its continued listing deficiencies on Nasdaq"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How much is CYAB's initial private placement?

The initial aggregate subscription amount is $15,610,120, consisting of $10,000,000 of new investment and $5,610,120 in subscription consideration to be satisfied through cancellation of $2,805,060 of outstanding company debt.

How much additional investment can CYAB receive?

The agreement contemplates up to $30,000,000 in additional investments over three years, in $500,000 tranches and subject to conditions. The press release says the investor committed, subject to conditions, to fund $5,000,000 within the first 12 months and another $5,000,000 within the first 18 months after the initial closing.

When is CYAB's initial closing expected?

The initial closing was expected on or about December 2026, but had not occurred as of November 16, 2026. It is subject to closing conditions, including stockholder approval and Cyabra satisfying its continued-listing deficiencies on Nasdaq.

What changed in CYAB's existing Series A and Series B warrants?

The exercise prices were reduced to $0.15 per share from $0.50 for Series A warrants and $0.45 for Series B warrants. Each series covers up to 8,045,980 common shares, and the amendment includes anti-dilution protection permitting a one-time exercise-price reduction following the company's reverse stock split.

What management changes does CYAB's purchase agreement contemplate?

Cyabra agreed to consider certain management changes within 10 days of the initial closing, including appointment of Joe Hayon as President and director, Nir Brenmiller as director, and Roy Hass as Chairman of the Board.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false 0002032341 0002032341 2026-11-16 2026-11-16 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): November 16, 2026

 

CYABRA, INC.

(Exact name of registrant as specified in its charter)

 

Delaware  001-43214  99-4210757
(State or other jurisdiction
of Incorporation)
  (Commission File Number)  (IRS Employer
Identification Number)

 

13 Gershon Shatz
Tel Aviv Israel
  6997543
(Address of registrant’s principal executive office)   (Zip code)

 

+972-54-768-8642

(Registrant’s telephone number, including area code)

 

 

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.0001 per share   CYAB   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 1.01 Entry into a Material Definitive Agreement

 

Private Placement Financing

 

On November 15, 2026, Cyabra Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Securities Purchase Agreement”) with certain institutional investors (the “Purchasers”), pursuant to which the Company agreed to issue and sell shares of newly to be designated Series D Preferred Stock and warrants to purchase shares of the Company’s common stock (the “Common Stock”) in a private placement (the “Offering”). The Company intends to use the net proceeds received from the Offering for working capital and other general corporate purposes.

 

The Securities Purchase Agreement contemplates an initial closing with an aggregate subscription amount of $15,610,120, consisting of $10,000,000 of new investment and $5,610,120 of subscription consideration to be satisfied through the cancellation of $2,805,060 of outstanding indebtedness of the Company. The Series D Preferred Stock has a stated value of $1,000 per share and an initial conversion price of $0.15 per share, subject to adjustment. The warrants have an initial exercise price of $0.15 per share, subject to adjustment, and are exercisable following the receipt of the required stockholder approval for a period of five years thereafter.

 

The initial closing is subject to the satisfaction or waiver of certain conditions set forth in the Purchase Agreement, including applicable stockholder approvals and conditions relating to the Company’s continued listing on Nasdaq Stock Market LLC (“Nasdaq”). As of the date of this Current Report on Form 8-K, the initial closing has not occurred, and the Company has not received the proceeds contemplated by the initial closing. There can be no assurance that the initial closing will occur on the anticipated terms or at all.

 

The Securities Purchase Agreement also contemplates additional investments of up to $30,000,000 in tranches of $500,000 each, for a three year period following the initial closing, subject to the terms and conditions set forth therein, including applicable equity conditions. There can be no assurance that any such additional investments will be made.

 

The Series D Preferred Stock will not have any voting rights. Upon any liquidation, dissolution or winding-up of the Company, after the satisfaction in full of the debts of the Company and payment of the liquidation preference to any senior securities, holders of Series D Preferred Stock shall be entitled to be paid, on a pari passu basis with the payment of any liquidation preference afforded to holders of any parity securities.

 

In connection with the Securities Purchase Agreement, the Company entered into a Registration Rights Agreement with the Purchasers, pursuant to which the Company agreed to register for resale the shares of common stock issuable upon conversion of the Series D Preferred Stock and exercise of the warrants, subject to the terms and conditions thereof. The Company is required to file such registration statement within two days following the initial closing of the Offering.

 

Pursuant to the terms of the Securities Purchase Agreement, the Company also agreed to consider making certain management changes within ten days of the initial closing of the Offering, which includes appointment Joe Hayon as President and director, Nir Brenmiller as director and Roy Hass as Chairman of the Board.

 

The securities are being offered and sold in reliance upon an exemption from the registration requirements of the Securities Act of 1933, as amended, pursuant to Section 4(a)(2) thereof and/or Regulation D thereunder.

 

The foregoing descriptions of the Securities Purchase Agreement, the Registration Rights Agreement, the Certificate of Designation of Preferences, Rights and Limitations of the Series D Preferred Stock and the warrants do not purport to be complete and are qualified in their entirety by reference to such documents, which are filed as Exhibits 10.1, 10.2, 3.1 and 4.1, respectively, to this this Current Report on Form 8-K and incorporated herein by reference.

 

1

 

 

Warrant Amendment

 

On November 15, 2026, the Company and the lead investor from the private placement offering conducted in July 2026, entered into a warrant amendment agreement whereby the Company agreed to reduce the exercise price of the Company’s Series A warrant to purchase up to 8,045,980 shares of Common Stock and the Company’s Series B warrant to purchase up to 8,045,980 shares of Common Stock from $0.50 and $0.45, respectively, to $0.15 per share, as well as including an anti-dilution protection mechanism permitting a one-time reduction of the exercise price following the Company’s reverse stock split. The investor provided the Company with a waiver of its certain variable rate transaction restriction to permit the Company to enter into the Securities Purchase Agreement and the Purchase Agreement.

 

Item 3.02 Unregistered Sales of Equity Securities.

 

The response to this item is included in Item 1.01, Entry into a Material Definitive Agreement, and is incorporated herein in its entirety.

 

Item 8.01 Other Events.

 

On November 16, 2026, the Company issued a press release relating to the announcement of the Offering. A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

 

Forward-Looking Statements

 

Certain information contained in this report consists of forward-looking statements for purposes of the federal securities law that involve risks, uncertainties and assumptions that are difficult to predict. Words such as “will,” “would,” “may,” “intends,” “potential,” and similar expressions, or the use of future tense, identify forward-looking statements, but their absence does not mean that a statement is not forward-looking. Such forward-looking statements are not guarantees of performance and actual actions or events could differ materially from those contained in such statements. For example, the Company is using forward-looking statements when it discusses issuance of securities subject to Stockholder Approval. For additional information about factors that could cause actual results to differ materially from those described in the forward-looking statements, please refer to the Company’s filings with the SEC. The forward-looking statements contained in this report speak only as of the date of this report and the Company undertakes no obligation to publicly update any forward-looking statements to reflect changes in information, events or circumstances after the date of this report, unless required by law.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

3.1   Form of Certificate of Designation of Preferences, Rights and Limitations of Series D Convertible Preferred Stock
4.1   Form of Common Warrant
10.1   Form of Securities Purchase Agreement
10.2   Form of Registration Rights Agreement
99.1   Press release dated November 16, 2026
104   Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)

 

2

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: November 16, 2026 CYABRA, INC.
   
  By: /s/ Dan Brahmy
  Name: Dan Brahmy
  Title:  Chief Executive Officer

 

3

Exhibit 99.1

 

Cyabra Announces Pricing of Up to $45 Million Strategic Investment to Scale Its Sovereign AI Information-Warfare Platform

 

Initial closing consists of a $15 million investment- $10 million in cash and an additional $5 million in conversion of outstanding debt

 

The Company has the opportunity to receive additional investments of up to $30 million within the next three years

 

New York, NY, November 16, 2026 (GLOBE NEWSWIRE) -- Cyabra, Inc. (Nasdaq: CYAB) (“Cyabra” or the “Company”), a provider of information-warfare technology that helps intelligence agencies and enterprises detect coordinated hostile activity and identify the networks behind it, today announced an investment agreement with institutional investors for up to $40 million in new investment in the Company over 3 years and the cancellation of approximately $3 million of outstanding debt.

 

The investment targets to scale delivery capacity of the Company’s sovereign information warfare platform, to meet growing demand and support the Company’s long-term milestones. It is also expected to drive the Company’ growth in leading markets and accelerate the rollout of additional technological capabilities across Cyabra’s existing product portfolio and expand its reach among U.S. federal agencies, international intelligence organizations, and fortune 500 enterprise customers. Building on recent multi-year contracts, within ten days of the initial closing, Cyabra intends to add seasoned public-company executives to its management team and Board to lead commercial expansion and scale the business, subject to corporate approvals.

 

The parties have agreed to an initial closing of a $10 million cash investment in the Company and an additional $5.6 million in conversion of outstanding debt. The agreement also gives the Company the opportunity to receive up to an additional $30 million within three years of which the Investor has committed, subject to certain conditions set forth in the purchase agreement, to fund $5 million within the first 12 months after the initial closing date and another $5 million within the first 18 months after the initial closing date.

 

The Company has entered into a securities purchase agreement with institutional investors for the purchase and sale of up to an aggregate of $40 million. The initial closing of $15.6 million includes issuance of preferred stock, which initially be convertible into shares of common stock at an initial conversion price of $0.15 per share and warrants. The warrants will have an initial exercise date following stockholder approval and will have a term of five years. The Company has agreed to call a shareholder meeting to approve the issuance of the common stock issuable upon conversion of the preferred stock and issuable upon exercise of the warrants. The investors will have an additional investment right of up to an additional $30,000,000 over a three-year period in tranches of $500,000. For the initial closing, an aggregate of $15.6 million of the subscription amount represents a $10 million new cash investment, and $5.6 million represents subscription consideration satisfied by cancellation of $2.8 million of outstanding debt of the Company.

 

The initial closing of the offering is expected to occur on or about December 2026, subject to the satisfaction of customary closing conditions, as well as other conditions, including the approval of the issuance of the securities at a stockholders meeting and the Company satisfying its continued listing deficiencies on Nasdaq. The purchase agreement also contemplates the Company entering into a $50 million equity line of credit (the “ELOC”).  The final terms of the ELOC are being negotiated and it is anticipated to be executed together with the closing of the purchase agreement. The Company currently intends to use the net proceeds from the offering for working capital and other general corporate purposes. The Company also believes the receipt of the funding from the offering will assist the Company in maintaining its Nasdaq listing.

 

 

 

 

Dan Brahmy, Co-Founder and CEO of Cyabra stated. “This strategic funding, once closed, is expected to provide the balance-sheet strength to scale our information warfare defense technologies, where global demand for sovereign cognitive defense is surging.”

 

The offer and sale of the foregoing securities is being made in reliance on an exemption from the registration requirement under Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”), and/or Regulation D promulgated thereunder, and applicable state securities laws, and the securities have not been and will not initially be registered under the Securities Act, or applicable state securities laws. Accordingly, the securities may not be offered or sold in the United States except pursuant to an effective registration statement or an applicable exemption from the registration requirements of the Securities Act and such applicable state securities laws. The Company has agreed to file a registration statement with the U.S. Securities and Exchange Commission (the “SEC”) covering the resale of the shares of common stock issuable upon conversion of the preferred stock and issuable upon exercise of the warrants.

 

This press release shall not constitute an offer to sell or the solicitation of an offer to buy the securities being offered, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

 

About Cyabra

 

Cyabra is a company that builds and deploys information warfare technologies to defend national security interests and enterprise organizations. Combining advanced AI with defense expertise, Cyabra identifies coordinated inauthentic activity, exposes influence operations, and delivers actionable intelligence to support national security and critical decision-making.

 

For more information, visit www.cyabra.com.

 

Contact

 

Investors: ir@cyabra.com
Media: pr@cyabra.com

Forward-Looking Statements

 

This press release contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that are not historical statements of fact and statements regarding Cyabra’s intent, belief, or expectations, including, but not limited to, statements regarding Cyabra’s future results of operations and financial position, planned products and services, business strategy and plans, market size and growth opportunities, competitive position and market trends. Some of these forward-looking statements can be identified by the use of forward-looking words, including “may,” “should,” “expect,” “intend,” “will,” “estimate,” “anticipate,” “believe,” “predict,” “plan,” “targets,” “projects,” “could,” “would,” “continue,” “forecast” or the negatives of these terms or variations of them or similar expressions. For example, the Company is using forward-looking statements in this press release when it discusses the expected proceeds, the intended use of proceeds, the expected initial closing date, the potential for additional investments over a three year period, and that the strategic funding, once closed, is expected to provide the balance-sheet strength and operational runway to scale its technology infrastructure at the exact moment global demand for sovereign cognitive defense is surging. These statements relate to future events and involve known and unknown risks, uncertainties, and other factors which may cause actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Such factors include those set forth in Cyabra’s filings with the SEC. Prospective investors are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date of this press release. Cyabra undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.

 

 

 

 

Filing Exhibits & Attachments

8 documents

Keep reading